Orient Europharma Co Ltd (4120) — Free Cash Flow Generation Index
Orient Europharma Co Ltd (4120) has a Free Cash Flow Generation Index of -1.68x as of June 2025. Free cash flow of NT$-55.78 Million represents -2% of operating cash flow (NT$33.25 Million). Read 4120 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Orient Europharma Co Ltd Free Cash Flow Generation Index (2015–2023)
Historical FCF Generation Index trend for Orient Europharma Co Ltd across 8 annual periods. Explore Orient Europharma Co Ltd (4120) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Orient Europharma Co Ltd (2015–2023)
Year-by-year Free Cash Flow Generation Index for Orient Europharma Co Ltd. For the full company profile including market capitalisation, see 4120 market cap overview.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.56x | NT$-36.03 Million | NT$64.67 Million | NT$100.70 Million | ▲ +97.1% |
| 2021 | -19.19x | NT$-1.49 Billion | NT$77.65 Million | NT$1.56 Billion | ▼ -3227.5% |
| 2020 | 0.61x | NT$373.43 Million | NT$608.55 Million | NT$232.78 Million | ▲ +186.6% |
| 2019 | 0.21x | NT$48.68 Million | NT$227.37 Million | NT$124.98 Million | ▲ +84.2% |
| 2018 | 0.12x | NT$26.88 Million | NT$231.31 Million | NT$201.61 Million | ▼ -80.8% |
| 2017 | 0.61x | NT$364.28 Million | NT$601.08 Million | NT$367.66 Million | ▼ -79.9% |
| 2016 | 3.02x | NT$336.05 Million | NT$111.24 Million | NT$224.81 Million | ▲ +122.7% |
| 2015 | 1.36x | NT$873.51 Million | NT$643.97 Million | NT$229.54 Million | — |